You can buy or sell ADPT and other stocks, options, and ETFs commission-free!
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA. The listed name for ADPT is Adaptive Biotechnologies Corporation Common Stock.
52 Week High
52 Week Low
— per share
Expected Feb 24, After Hours